Long gamma nail versus sliding hip screw for the treatment of unstable pertrochanteric hip fractures

ISRCTN ISRCTN79362886
DOI https://doi.org/10.1186/ISRCTN79362886
Secondary identifying numbers N/A
Submission date
26/03/2009
Registration date
07/04/2009
Last edited
07/04/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Timothy Chesser
Scientific

Department of Trauma and Orthopaedics
Frenchay Hospital
Frenchay Park Road
Frenchay
Bristol
BS16 1JE
United Kingdom

Study information

Study designSingle centre randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleA prospective randomised controlled trial comparing the long gamma nail with the sliding hip screw for the treatment of unstable pertrochanteric hip fractures
Study objectivesThere is no difference in outcome between the sliding hip screw and the long gamma nail in the treatment of unstable pertrochanteric hip fractures.
Ethics approval(s)South West Local Research Ethics Committee approved on the 12th May 2003 (ref: Frenchay LREC/2003/20)
Health condition(s) or problem(s) studiedUnstable pertrochanteric fractures of the proximal femur
InterventionPatients entered into the trial were randomised to fixation of their proximal femoral fracture by either a sliding hip screw (Omega® II, Stryker, UK) or a long gamma nail (Dyax®, Stryker, UK).

Randomisation was via sealed envelopes. Neither participants nor physicians were blinded to treatment.
Intervention typeOther
Primary outcome measureRe-operation within the first post-operative year.
Secondary outcome measures1. Mortality in the first post-operative year
2. Requirement for a blood transfusion within one week of surgery
3. Length of hospital stay
4. Mobility and residency at one year
5. Euroqol EQ-5D at 3, 6 and 12 months post-operation
Overall study start date01/04/2003
Completion date01/04/2006

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants320
Key inclusion criteriaAll patients (both males and females) over the age of 18 years admitted to the treating hospital with an unstable pertrochanteric hip fracture.
Key exclusion criteria1. Pathological fractures
2. Previous proximal femoral fractures
3. Decision of the admitting physician
Date of first enrolment01/04/2003
Date of final enrolment01/04/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Department of Trauma and Orthopaedics
Bristol
BS16 1JE
United Kingdom

Sponsor information

North Bristol NHS Trust (UK)
Hospital/treatment centre

Frenchay Hospital
Frenchay Park Road
Frenchay
Bristol
BS16 1JE
England
United Kingdom

Website http://www.nbt.nhs.uk/
ROR logo "ROR" https://ror.org/036x6gt55

Funders

Funder type

Government

North Bristol NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/04/2010 Yes No